Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Morgan Stanley    MS

MORGAN STANLEY

(MS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Morgan Stanley : rates PMV as Equal-weight

01/13/2021 | 06:31pm EDT

Morgan Stanley notes Premier Investments' first-half operating income guidance at $221-233m not only implies a 75-80% year on year growth but is also ahead of the broker's full-year FY21 operating income forecast of $190m.

While the strong momentum is likely to continue in the near term, Morgan Stanley thinks earnings growth will decelerate in FY22 as conditions normalize.

Equal-weight rating with the target price unchanged at $18.40. Industry view: In-Line.

Sector: Retailing.

Target price is $18.40.Current Price is $25.35. Difference: ($6.95) - (brackets indicate current price is over target). If PMV meets the Morgan Stanley target it will return approximately -38% (excluding dividends, fees and charges - negative figures indicate an expected loss).

© 2021 Acquisdata Pty Ltd., source FN Arena

Stocks mentioned in the article
ChangeLast1st jan.
MORGAN STANLEY 2.41% 81.435 Delayed Quote.17.00%
PREMIER INVESTMENTS LIMITED -1.93% 26.42 End-of-day quote.12.38%
All news about MORGAN STANLEY
12:22pWALL STREET STOCK EXCHANGE : Wall Street Banks Do More With Less -- Heard on the..
DJ
11:02aMORGAN STANLEY AND SPELMAN COLLEGE  : Announce Inaugural Class of HBCU Scholars ..
BU
09:36aBOX  : Morgan Stanley Adjusts Price Target on Box to $25 From $23, Maintains Ove..
MT
09:19aRAYMOND JAMES FINANCIAL  : Morgan Stanley Adjusts Price Target on Raymond James ..
MT
09:09aIRHYTHM TECHNOLOGIES  : Morgan Stanley Cuts IRhythm Technologies to Equal-Weight..
MT
08:55aCVS HEALTH  : Morgan Stanley Adjusts Price Target on CVS Health to $92 From $86,..
MT
08:55aWALGREENS BOOTS ALLIANCE  : Morgan Stanley Adjusts Price Target on Walgreens Boo..
MT
08:42aNETFLIX  : to See Higher Net Additions, Better-Than-Expected Margins Post-Pandem..
MT
08:41aFASTENAL  : Morgan Stanley Adjusts Price Target on Fastenal to $53 From $49, Mai..
MT
08:35aMAGNA INTERNATIONAL  : Morgan Stanley Lifts Magna International to Equal-Weight ..
MT
More news
Financials (USD)
Sales 2021 52 616 M - -
Net income 2021 10 751 M - -
Net Debt 2021 147 B - -
P/E ratio 2021 13,3x
Yield 2021 1,86%
Capitalization 149 B 149 B -
EV / Sales 2021 5,62x
EV / Sales 2022 5,48x
Nbr of Employees 68 000
Free-Float 67,9%
Chart MORGAN STANLEY
Duration : Period :
Morgan Stanley Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORGAN STANLEY
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 87,99 $
Last Close Price 79,53 $
Spread / Highest target 40,8%
Spread / Average Target 10,6%
Spread / Lowest Target -15,8%
EPS Revisions
Managers and Directors
NameTitle
James Patrick Gorman Chairman & Chief Executive Officer
Jonathan M. Pruzan Chief Financial Officer & Executive Vice President
Robert Rooney Head-Technology, Operations & Firm Resilience
Sigal Zarmi Chief Information Officer & Managing Director
Daniel A. Simkowitz Head-Investment Management
Sector and Competitors